Drug Shortage Report for SUPREFACT
| Report ID | 104798 |
| Drug Identification Number | 02225166 |
| Brand name | SUPREFACT |
| Common or Proper name | Suprefact |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | BUSERELIN |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 2 |
| ATC code | L02AE |
| ATC description | HORMONES AND RELATED AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2020-01-29 |
| Actual start date | |
| Estimated end date | 2020-02-14 |
| Actual end date | 2020-02-18 |
| Shortage status | Resolved |
| Updated date | 2020-02-19 |
| Company comments | Delay in production - The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-02-19 | English | Compare |
| v4 | 2020-02-18 | French | Compare |
| v3 | 2020-02-18 | English | Compare |
| v2 | 2020-01-30 | French | Compare |
| v1 | 2020-01-30 | English | Compare |
Showing 1 to 5 of 5